302 related articles for article (PubMed ID: 15731588)
1. Polymorphism of mu-opioid receptor gene (OPRM1:c.118A>G) does not protect against opioid-induced respiratory depression despite reduced analgesic response.
Romberg RR; Olofsen E; Bijl H; Taschner PE; Teppema LJ; Sarton EY; van Kleef JW; Dahan A
Anesthesiology; 2005 Mar; 102(3):522-30. PubMed ID: 15731588
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic-pharmacodynamic modeling of morphine-6-glucuronide-induced analgesia in healthy volunteers: absence of sex differences.
Romberg R; Olofsen E; Sarton E; den Hartigh J; Taschner PE; Dahan A
Anesthesiology; 2004 Jan; 100(1):120-33. PubMed ID: 14695733
[TBL] [Abstract][Full Text] [Related]
3. Does the A118G polymorphism at the mu-opioid receptor gene protect against morphine-6-glucuronide toxicity?
Lötsch J; Zimmermann M; Darimont J; Marx C; Dudziak R; Skarke C; Geisslinger G
Anesthesiology; 2002 Oct; 97(4):814-9. PubMed ID: 12357145
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous measurement and integrated analysis of analgesia and respiration after an intravenous morphine infusion.
Dahan A; Romberg R; Teppema L; Sarton E; Bijl H; Olofsen E
Anesthesiology; 2004 Nov; 101(5):1201-9. PubMed ID: 15505457
[TBL] [Abstract][Full Text] [Related]
5. The mu-opioid receptor gene polymorphism 118A>G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carriers.
Oertel BG; Schmidt R; Schneider A; Geisslinger G; Lötsch J
Pharmacogenet Genomics; 2006 Sep; 16(9):625-36. PubMed ID: 16906017
[TBL] [Abstract][Full Text] [Related]
6. Relevance of frequent mu-opioid receptor polymorphisms for opioid activity in healthy volunteers.
Lötsch J; Geisslinger G
Pharmacogenomics J; 2006; 6(3):200-10. PubMed ID: 16415919
[TBL] [Abstract][Full Text] [Related]
7. How much oxycodone is needed for adequate analgesia after breast cancer surgery: effect of the OPRM1 118A>G polymorphism.
Cajanus K; Kaunisto MA; Tallgren M; Jokela R; Kalso E
J Pain; 2014 Dec; 15(12):1248-56. PubMed ID: 25239082
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism of the micro-opioid receptor gene (OPRM1 118A>G) affects fentanyl-induced analgesia during anesthesia and recovery.
Wu WD; Wang Y; Fang YM; Zhou HY
Mol Diagn Ther; 2009; 13(5):331-7. PubMed ID: 19791836
[TBL] [Abstract][Full Text] [Related]
9. Comparison of morphine-6-glucuronide and morphine on respiratory depressant and antinociceptive responses in wild type and mu-opioid receptor deficient mice.
Romberg R; Sarton E; Teppema L; Matthes HW; Kieffer BL; Dahan A
Br J Anaesth; 2003 Dec; 91(6):862-70. PubMed ID: 14633759
[TBL] [Abstract][Full Text] [Related]
10. The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone.
Boswell MV; Stauble ME; Loyd GE; Langman L; Ramey-Hartung B; Baumgartner RN; Tucker WW; Jortani SA
Pain Physician; 2013; 16(3):E227-35. PubMed ID: 23703421
[TBL] [Abstract][Full Text] [Related]
11. The effect of OPRM1 and COMT genotypes on the analgesic response to intravenous fentanyl labor analgesia.
Landau R; Liu SK; Blouin JL; Carvalho B
Anesth Analg; 2013 Feb; 116(2):386-91. PubMed ID: 23302985
[TBL] [Abstract][Full Text] [Related]
12. Randomized placebo-controlled trial of the activity of the morphine glucuronides.
Penson RT; Joel SP; Bakhshi K; Clark SJ; Langford RM; Slevin ML
Clin Pharmacol Ther; 2000 Dec; 68(6):667-76. PubMed ID: 11180027
[TBL] [Abstract][Full Text] [Related]
13. The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease.
Klepstad P; Rakvåg TT; Kaasa S; Holthe M; Dale O; Borchgrevink PC; Baar C; Vikan T; Krokan HE; Skorpen F
Acta Anaesthesiol Scand; 2004 Nov; 48(10):1232-9. PubMed ID: 15504181
[TBL] [Abstract][Full Text] [Related]
14. Naloxone reversal of morphine- and morphine-6-glucuronide-induced respiratory depression in healthy volunteers: a mechanism-based pharmacokinetic-pharmacodynamic modeling study.
Olofsen E; van Dorp E; Teppema L; Aarts L; Smith TW; Dahan A; Sarton E
Anesthesiology; 2010 Jun; 112(6):1417-27. PubMed ID: 20461002
[TBL] [Abstract][Full Text] [Related]
15. The μ-opioid receptor gene polymorphism 118A>G weakens the pharmacological action of buprenorphine.
Imai H; Morita M; Morita H; Ohyama T; Tanaka S; Uchida S; Namiki N; Uemura N; Ohashi K
Int J Clin Pharmacol Ther; 2020 Nov; 58(11):626-633. PubMed ID: 32870152
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological consequence of the A118G μ opioid receptor polymorphism on morphine- and fentanyl-mediated modulation of Ca²⁺ channels in humanized mouse sensory neurons.
Mahmoud S; Thorsell A; Sommer WH; Heilig M; Holgate JK; Bartlett SE; Ruiz-Velasco V
Anesthesiology; 2011 Nov; 115(5):1054-62. PubMed ID: 21926562
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment.
Walter C; Lötsch J
Pain; 2009 Dec; 146(3):270-275. PubMed ID: 19683391
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action.
Lötsch J; Skarke C; Wieting J; Oertel BG; Schmidt H; Brockmöller J; Geisslinger G
Clin Pharmacol Ther; 2006 Jan; 79(1):72-89. PubMed ID: 16413243
[TBL] [Abstract][Full Text] [Related]
19. The Relevance of the OPRM1 118A>G Genetic Variant for Opioid Requirement in Pain Treatment: A Meta-Analysis.
Zhang X; Liang Y; Zhang N; Yan Y; Liu S; Fengxi H; Zhao D; Chu H
Pain Physician; 2019 Jul; 22(4):331-340. PubMed ID: 31337162
[TBL] [Abstract][Full Text] [Related]
20. Morphine-6beta-glucuronide rapidly increases pain sensitivity independently of opioid receptor activity in mice and humans.
van Dorp EL; Kest B; Kowalczyk WJ; Morariu AM; Waxman AR; Arout CA; Dahan A; Sarton EY
Anesthesiology; 2009 Jun; 110(6):1356-63. PubMed ID: 19461298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
